Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Survival motor neuron protein 1 (SMN1) is a ubiquitously expressed protein best known as a critical motor neuron maintenance factor and a cornerstone for snRNP assembly, essential for correct mRNA splicing. SMN1 works as part of a multi-protein SMN complex that controls the maturation and localization of snRNPs, formation of nuclear gems, and neuronal outgrowth. Genetic deficiency of SMN1 leads to spinal muscular atrophy (SMA) due to selective degeneration of spinal motor neurons, and SMA severity is influenced by SMN2 copy number. Therapies target the gene, protein, or related homologues in attempts to boost SMN protein levels or replace the gene to rescue motor neuron function.
Nusinersen: antisense oligonucleotide modulates SMN2 pre-mRNA splicing, increases functional SMN protein levels. Onasemnogene abeparvovec-xioi: gene replacement therapy providing functional SMN1 gene. Risdiplam: small molecule modulating SMN2 splicing and protein production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Survival motor neuron protein 1 (SMN1).